Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Valens Company Inc (The) Ordinary Shares VLNCF

The Valens Co Inc is a developer and manufacturer of cannabinoid-based products. The company's extraction methods are CO2, ethanol, hydrocarbon, solvent-less, and terpene extraction. Its products are Tinctures, Capsules, Beverages, and Vape cartridges among others. Its reportable segments are Cannabis operations, Analytical testing, and Corporate. The company has a business presence in Canada and other countries, and it generates a majority of revenue from the Cannabis operations segment.


OTCQX:VLNCF - Post by User

Post by mesa1on May 19, 2021 11:00am
222 Views
Post# 33229781

FP/wire say Valens has high hopes for Green Roads buy ...

FP/wire say Valens has high hopes for Green Roads buy ...

FP/wire say Valens has high hopes for Green Roads buy

2021-04-28 04:43 PT - In the News

The Financial Post reports in its Wednesday edition that Valens has signed a deal to buy Florida-based Green Roads as part of its initial expansion into the United States. A Bloomberg dispatch to the Post says that Valens, based in Kelowna, B.C., will acquire the company for $40-million (U.S.) in cash and stock, plus $20-million (U.S.) if earnings-based targets are met. Green Roads sells products with cannabidiol, or CBD -- the non-psychoactive compound in the marijuana plant -- on-line and through 7,000 retail locations. The deal will allow Valens to immediately enter the U.S. CBD market. The combined company would have had sales of $111.6-million in 2020. Valens generated revenue of $83.8-million in its last fiscal year. Valens chief executive officer Tyler Robson said in a statement that the deal "will help us create an attractive platform in a growing health and wellness market." The deal is expected to be accretive to earnings in 2021. The Green Roads brand had the second-largest share of the U.S. CBD market in last year's third quarter, according to the companies. Valens shares moved up on the news. They ended Tuesday up 15 cents at $3.43 in Toronto. Marijuana remains illegal at the U.S. federal level.


<< Previous
Bullboard Posts
Next >>